MetLife, Inc. $MET Stock Acquired by Focus Advisor Solutions LLC

Focus Advisor Solutions LLC lifted its position in MetLife, Inc. (NYSE:MET – Free Report) by 149.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 32,413 shares of the financial services provider’s stock after buying an additional 19,405 shares during the period. Focus Advisor Solutions LLC’s holdings in MetLife were worth $3,052,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. BlackRock Inc. purchased a new position in MetLife in the 2nd quarter worth approximately $4,381,692,000. Pzena Investment Management LLC bought a new position in MetLife in the 2nd quarter valued at approximately $941,792,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in MetLife by 5.9% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 6,026,518 shares of the financial services provider’s stock valued at $509,904,000 after purchasing an additional 336,794 shares during the last quarter. Bank of America Corp DE purchased a new stake in MetLife during the 2nd quarter valued at $455,424,000. Finally, Legal & General Group Plc bought a new stake in shares of MetLife in the 2nd quarter worth $326,904,000. Hedge funds and other institutional investors own 94.99% of the company’s stock.

MetLife Stock Performance

MET stock opened at $95.59 on Friday. The company has a market cap of $60.07 billion, a P/E ratio of 12.46, a price-to-earnings-growth ratio of 0.90 and a beta of 0.79. MetLife, Inc. has a 1 year low of $67.33 and a 1 year high of $106.72. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.21 and a quick ratio of 0.21. The stock’s fifty day moving average price is $99.02 and its 200-day moving average price is $87.43.

MetLife (NYSE:MET – Get Free Report) last issued its quarterly earnings data on Wednesday, November 4th. The financial services provider reported $2.78 EPS for the quarter, topping the consensus estimate of $2.77 by $0.01. The company had revenue of $20.52 billion during the quarter, compared to analyst estimates of $19.86 billion. MetLife had a return on equity of 25.71% and a net margin of 6.21%. MetLife’s revenue was up 18.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.34 earnings per share. On average, equities analysts forecast that MetLife, Inc. will post 9.94 earnings per share for the current year.

MetLife Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 8th. Shareholders of record on Tuesday, November 3rd will be given a $0.5925 dividend. This represents a $2.37 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend is Tuesday, November 3rd. MetLife’s dividend payout ratio (DPR) is presently 30.90%.

MetLife declared that its board has initiated a share repurchase program on Wednesday, August 5th that allows the company to buy back $3 billion in outstanding shares. This repurchase authorization allows the financial services provider to reacquire up to 4.8% of its shares through open market purchases. Share repurchase programs are often an indication that the company’s leadership believes its shares are undervalued.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on MET. JPMorgan Chase & Co. boosted their price target on MetLife from $108.00 to $110.00 and gave the stock an “overweight” rating in a research note on Thursday, October 15th. Jefferies Financial Group boosted their target price on MetLife from $103.00 to $115.00 and gave the stock a “buy” rating in a research report on Monday, August 10th. Wall Street Zen upgraded shares of MetLife from a “hold” rating to a “buy” rating in a research note on Sunday, November 15th. UBS Group raised their price target on shares of MetLife from $105.00 to $110.00 and gave the company a “buy” rating in a report on Tuesday, October 6th. Finally, Evercore reiterated a “mixed” rating on shares of MetLife in a research note on Monday, August 24th. Fourteen equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $107.12.

Check Out Our Latest Report on MET

Insider Activity

In other MetLife news, CEO Michel Khalaf sold 187,425 shares of the business’s stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $102.97, for a total transaction of $19,299,152.25. Following the completion of the sale, the chief executive officer directly owned 759,013 shares in the company, valued at $78,155,568.61. The trade was a 19.80% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.40% of the stock is currently owned by corporate insiders.

MetLife Company Profile

(Free Report)

MetLife, Inc. is a global financial services company best known for providing insurance, employee benefits and retirement-related products. Its offerings include life, dental and disability insurance, annuities, and products and services designed to help individuals and employers plan for financial protection and retirement. The company serves individuals, businesses and institutions in the United States and international markets, including countries in Latin America, Asia, Europe and the Middle East.

Featured Articles

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.